Robert Boyd
21Patents
5h-index
7Co-inventors
62Inventor score
Filing activity: Oct 28, 1997 → Jan 7, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5984896A | Fixated catheter | Human Necessities | 144 | Expired |
| US9181184B2 | Method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives | Chemistry; Metallurgy | 25 | Active |
| US8940766B2 | Methods for preventing and/or treating lysosomal storage disorders | Physics | 19 | Active |
| US8604206B2 | Compositions for preventing and/or treating degenerative disorders of the central nervous system | Chemistry; Metallurgy | 6 | Active |
| US8604057B2 | Compositions for preventing and/or treating lysosomal storage disorders | Chemistry; Metallurgy | 5 | Active |
| US8304429B2 | Methods for preventing and/or treating degenerative disorders of the central nervous system | Human Necessities | 3 | Active |
| US9409862B2 | Compositions for preventing and/or treating degenerative disorders of the central nervous system | Chemistry; Metallurgy | 1 | Active |
| US10035766B2 | Compositions for preventing and/or treating lysosomal storage disorders | Chemistry; Metallurgy | 1 | Active |
| US9464050B2 | Compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system | Electricity | 1 | Active |
| US9044437B2 | Method for treating alzheimer's disease using pharmacological chaperones to increase the activity of gangliosidases | Human Necessities | 0 | Active |
| US10224333B2 | Compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system | Electricity | 0 | Active |
| US9994589B2 | Compounds and methods for the treatment of alzheimer's disease and/or cerebral amyloid angiopathy | Chemistry; Metallurgy | 0 | Active |
| US10793583B2 | Compounds and methods for the treatment of Alzheimer's disease and/or cerebral amyloid angiopathy | Chemistry; Metallurgy | 0 | Active |
| US9931353B2 | Method for treating cerebral amyloid angiopathy using pharmacological chaperones to increase the activity of gangliosidases | Human Necessities | 0 | Active |
| US8933068B2 | Composition and methods of treatment of bacterial meningitis | Human Necessities | 0 | Active |
| US11602528B2 | Method for the treatment of Pompe disease using 1-deoxynojirimycin derivatives | Chemistry; Metallurgy | 0 | Active |
| US10174054B2 | Compounds and methods for the treatment of Alzheimer's disease and/or cerebral amyloid angiopathy | Chemistry; Metallurgy | 0 | Active |
| US11358926B2 | Compositions for preventing and/or treating degenerative disorders of the central nervous system and/or lysosomal storage disorders | Chemistry; Metallurgy | 0 | Active |
| US10421724B2 | Compositions for preventing and/or treating degenerative disorders of the central nervous system | Chemistry; Metallurgy | 0 | Active |
| US9750733B2 | Compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system | Electricity | 0 | Active |
| US9598438B2 | Sugar derivatives comprising sulfur-containing moieties and methods of making same and methods of using the same for the treatment of MPS IIIC | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.